Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
Press JZ, De Luca A, Boyd N, Young S, Troussard A, Ridge Y, Kaurah P, Kalloger SE, Blood KA, Smith M, Spellman PT, Wang Y, Miller DM, Horsman D, Faham M, Gilks CB, Gray J, Huntsman DG.
Press JZ, et al. Among authors: kalloger se.
BMC Cancer. 2008 Jan 22;8:17. doi: 10.1186/1471-2407-8-17.
BMC Cancer. 2008.
PMID: 18208621
Free PMC article.